

提醒:代购产品,无质量问题不接受退换货,下单前请仔细核对信息。下单后请及时联系客服
核对商品价格,订单生效后再付款。
Discovery Antibodies/(S)(-)-Bay K8644/50 mg/B-351-50 mg
价格:
自营商城
解放采购
正品保障
及时交付
厂家直采
一站服务
货号:
品牌:
会员服务:
尊享会员价
贵宾专线
运费优惠
闪电退款
福利优惠
上门换新
友情提示
以上价格仅为参考,请联系客服询价。
免费咨询热线
4000-520-616
产品说明
Cat #: B-351 Lyophilized Powder Lyophilized PowderThis product is freeze dried. All water molecules have been removed.Bioassay Tested Bioassay TestedEvery lot is tried & tested in a relevant biological assay. Our BioassaySource SyntheticMW: 356.3Purity: >98% (HPLC)Form Lyophilized powder.Effective concentration 50 nM - 5 µM. Structure - + Chemical name (4S)-1,4-dihydro-2,6-dimethyl-5-nitro-4-[2-trifluoromethyl)phenyl]-3-pyridinecarboxylic acid methyl ester.Molecular formula C16H15 F3N2O4.CAS No.: 98625-26-4.Activity (S)(-)-Bay K8644 is an L-type Ca2+-channel activator. It displays vasoconstrictive effects in vivo1. References-Activity - + Franckowiak, G. et al. (1985) Eur. J. Pharmacol. 114, 223.Shipping and storage Shipped at room temperature. Product as supplied can be stored intact at room temperature for several weeks. For longer periods, it should be stored at -20°C.Solubility 100 mM in DMSO. Centrifuge all product preparations before use (10000 x g for 1 min).Storage of solutions Up to four weeks at 4°C or three months at -20°C. Our bioassay - + Alomone Labs (S)(-)-Bay K8644 increases L-type CaV channel currents heterologously expressed in Xenopus oocytes.A. Time course of CaV1.2 (co-expressed with α2δ1 and β1 auxiliary subunits) peak current amplitude, elicited by 100 ms voltage ramp from holding potential of -100 mV to +50 mV, delivered every 10 seconds. Application of 0.1 and 1 µM (S)(-)-Bay K8644 (#B-351) increases the CaV1.2 current (indicated by the horizontal bar). B. Representative current traces before and during application of 0.1 and 1 µM (S)(-)-Bay K8644 as indicated. References - Scientific background1. Hadley, R.W. and Hume, J.R. (1988) Circ. Res. 62, 97.2. Wei, X.Y. et al. (1986) J. Pharmacol. Exp. Ther. 239, 144. Scientific background - + (S)(-)-Bay K8644 is an L-type Ca2+-channel activator with positive inotropic, vasoconstrictive and behavioral effects in vivo. It is an enantiomer of (±)-Bay K8644. (S)(-)-Bay K8644 is a dihydropyridine that can, among other effects, constrict blood vessels and increase the force of contraction of the heart. The drug is thought to increase the entry of Ca2+ into cells by increasing the open-state probability of Ca2+ channels, either by prolonging the duration of individual openings or by increasing the number of openings. It was noted in early experiments with Bay K8644 that the dose-response curve is biphasic1. The action of (S)(-)-Bay K8644 was studied in rat tail artery and guinea pig ileal longitudinal smooth muscle using pharmacologic and radioligand binding assays. It induced concentration-dependent contractions in both smooth muscle preparations with EC50 values of 1.98-11 nM. With increasing concentrations, (S)(-)-Bay K8644 relaxed the tissue with IC50 values of 0.53-2.60 μM2.Target L-type Ca2+ channelsLyophilized PowderClick here to receive a 1 mg free trial sample! Certificate of AnalysisLast update: 24/09/2019(S)(-)-Bay K8644 (#B-351) is a highly pure, synthetic, and biologically active compound.For research purposes only, not for human use
Discovery®抗体是剑桥生物化学研究所(CRB)的新目录抗体业务。
CRB是世界上第二大多肽公司,也是抗体研究市场的领跑者,从目录业务到现在已有22年的休息期(1994-2016年),现在是第37年(2017年),CRB推出了一个全新的现成抗体业务,名为Discovery®抗体。
Discovery®抗体将专注于研究抗体(早期药物“Discovery”),并将补充我们非常成功和长期的定制抗体业务(www.crbdiscovery.com网站). 我们以新颖、复杂、稀有和翻译后修饰的特异性抗体而闻名,这些备受追捧的目标将出现在我们的发现®抗体目录范围内。
我们于2017年2月推出了我们的发现®抗体,一年后发现®肽,大约240年后,詹姆斯·库克船长(他那个时代最伟大的探险家)于1776年从英国乘“发现”号船出发,包租全球的新水域和“发现”新大陆。因此,“发现”这个名字似乎适合东北部的一家制造商——詹姆斯·库克的家乡。
在17世纪末对世界各地新发现的土地的探索和2000年医学研究的新“发现”以及人类基因组的绘制之间产生了进一步的相似之处。
有关更多详情,请参阅我们发布的Discovery®抗体的新闻稿
剑桥研究生物化学(www.crbdiscovery.com网站)是一家领先的定制肽和抗体工具的独立生产商,为全球制药、生命科学和学术领域的研究人员提供服务。其产品的主要用途是作为定制的实验室级试剂,用于证明早期药物发现中的主要研究,并支持临床研究中的生物标记物方案。该公司生产各种口味的肽,从简单到改性,稳定,从毫克到克标到最高纯度的染料标签。
Discovery®抗体是剑桥生物化学研究所(CRB)的新抗体目录业务
新品排行榜
1
Discovery Antibodies/Amitriptyli...
2
Discovery Antibodies/Cyclothiazi...
3
Discovery Antibodies/Anti-CALHM1...
4
Discovery Antibodies/Anti-CACNA1...
5
Discovery Antibodies/Anti-BAI2 (...
6
Discovery Antibodies/Anti-Aquapo...
7
Discovery Antibodies/Anti-SLC15A...
8
Discovery Antibodies/Guinea pig ...
9
Discovery Antibodies/Anti-KV1.3 ...
10
Discovery Antibodies/(S)(-)-Bay ...
文章排行榜
1
羌活调控klotho基因表达的活性成分及其抗脑衰老研究基金科学网构建全球华人科学社区,EditSprings,艾德思
2
ACCELRYS DELIVERS ANNOTATIONS OF 89% OF HUMAN PROTEOME TO CONSORTIUM MEMBERS
3
2009年“芯片、计算机、作物”学术研讨会
4
肽免疫 - CRB Discovery,通用医疗
5
青岛——基因组、转录组寒假学习班
6
GE医疗便携式乳腺X射线仪获FDA认证
7
GE:携人性化创新产品亮相ChinaMed
8
Accelrys公司发布Discovery Studio Modeling最新版本
9
Discovery Studio Modeling个人电脑上的全新分子建模环境,专业的生物分子模拟软件
10
美国Accelrys公司与美国SYMYX公司于2010年4月7日宣布合并